![BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA](https://mma.prnewswire.com/media/720424/Lilly.jpg?p=facebook)
BAQSIMI™ (glucagon) Nasal Powder 3 mg, the First and Only Nasally Administered Glucagon to Treat Severe Hypoglycemia in Adults and Children with Diabetes Ages Four Years and Older, Approved by FDA
![Nasal glucagon spray device (left) and injectable glucagon kit (right). | Download Scientific Diagram Nasal glucagon spray device (left) and injectable glucagon kit (right). | Download Scientific Diagram](https://www.researchgate.net/publication/317257669/figure/fig1/AS:612114674749440@1522950919653/Nasal-glucagon-spray-device-left-and-injectable-glucagon-kit-right.png)
Nasal glucagon spray device (left) and injectable glucagon kit (right). | Download Scientific Diagram
![Disponible en España baqsimi, el primer y único glucagón por vía nasal para las hipoglucemias graves - Revista Pharma Market Disponible en España baqsimi, el primer y único glucagón por vía nasal para las hipoglucemias graves - Revista Pharma Market](https://www.phmk.es/img_noticias/2021/02/FOTO2063.jpg)